CIBC Private Wealth Group
IRON icon

CIBC Private Wealth Group’s Disc Medicine IRON Stock Holding History

CIBC Private Wealth Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-388
Closed -$13.3K – 3223
2024
Q1 		$13.3K Buy
+388
New +$25.2K ﹤0.01% 2171

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CIBC Private Wealth Group's IRON Position: Q2 2024 in Review

CIBC Private Wealth Group sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 388 shares — an estimated $13.3K sold.

CIBC Private Wealth Group first reported a position in IRON in Q1 2024 and held it in 1 quarter. The position peaked at $13.3K in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • CIBC Private Wealth Group reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 388 Disc Medicine shares in Q2 2024, an estimated $13.3K.
  • CIBC Private Wealth Group first reported a position in Disc Medicine in Q1 2024 and held it in 1 quarter.
  • CIBC Private Wealth Group's Disc Medicine position peaked at $13.3K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on CIBC Private Wealth Group's 13F filing for Q2 2024, filed 9 Aug 2024.